相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer
Snita Sinukumar et al.
EJSO (2021)
Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States
Courtney A. Penn et al.
JAMA NETWORK OPEN (2020)
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
Claudia Marchetti et al.
ONCOTARGETS AND THERAPY (2019)
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S. Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
History of Peritoneal Surface Malignancy Treatment in Japan
Yutaka Yonemura et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2019)
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
M. R. Mirza et al.
ANNALS OF ONCOLOGY (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ovarian Cancer Treatment - Are We Getting Warmer?
David R. Spriggs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
Nicoletta Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
Veria Khosrawipour et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer
S. Gouy et al.
GYNECOLOGIC ONCOLOGY (2016)
The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review
Aditi Bhatt et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2016)
Hyper:thermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis
Y. R. Huo et al.
EJSO (2015)
A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
Luis M. Chiva et al.
GYNECOLOGIC ONCOLOGY (2015)
The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction
Pedro Antonio Cascales-Campos et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2012)
Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
Lana Bijelic et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Marcello Deraco et al.
GYNECOLOGIC ONCOLOGY (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
Kurt Van der Speeten et al.
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY (2011)
Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data
Paul H. Sugarbaker et al.
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY (2011)
Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study
C. Pomel et al.
EJSO (2010)
Phase i trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy
Lawrence E. Harrison et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
P. H. Sugarbaker
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2007)
How do cells respond to their thermal environment?
JR Lepock
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
The transport barrier in intraperitoneal therapy
MF Flessner
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia
O Glehen et al.
LANCET ONCOLOGY (2004)
分享论文
